Research Review Multiple Myeloma Summit Highlights include: High risk MM outcomes 5-year results for CyBorD MRD for guiding myeloma treatment Burden of MM in NZ Download hereContinue Reading
Issue 28 of Multiple Myeloma Research Review. Highlights include: Elotuzumab monotherapy for smouldering MM Thereapetuc vulnerability of MM to Pri-17-92 inhibition Identification of novel mutational drivers reveals oncogene dependencies in...Continue Reading
Issue 27 of Multiple Myeloma Research Review Highlights include: Low dose lenalidomide + dexamethasone in newly diagnosed POEMS syndrome. Loss of heterozygosity indicates homologous repair deficiency in MM. Treatment intensification...Continue Reading
